Israel’s Defense Ministry has announced that it will begin the first human trials of its coronavirus vaccine on Sunday, November 1. The Israel Institute for Biological Research (IIBR), a government-funded lab, will begin conducting human trials with just two participants. It will then increase to 80 participants throughout the month of November. If they respond well to the vaccine by developing antibodies to the virus, the trials will expand to 960 people in December. If the trials continue to prove successful, then 30,000 people will test the vaccine in April or May 2021. Prof. Shmuel Shapira said the institute began working on the vaccine in early February and is almost complete. The lab announced in June it had successfully completed trials on rodents.
Some description text for this item